Fact CheckerSign in

NCT07454954Not yet recruiting

The Effect of Blood Flow Restriction Training Combined With Transcranial Magnetic Stimulation on Limb Function in Hemiplegic Patients After Stroke

Source: ClinicalTrials.gov · Last updated 6 Mar 2026

Brief summary (registry, in English)

This randomized controlled trial aims to evaluate whether combining blood flow restriction training (BFRT) with repetitive transcranial magnetic stimulation (rTMS) improves limb function in stroke patients with hemiplegia. A total of 69 participants will be randomly assigned to three groups: conventional rehabilitation alone (control group), conventional rehabilitation plus rTMS, or conventional rehabilitation plus BFRT combined with rTMS. The intervention period is 4 weeks, with assessments conducted at baseline and at the end of treatment. The primary outcome is the change in upper extremity Fugl-Meyer Assessment (FMA-UE) score, which measures motor function recovery. Secondary outcomes include Wolf Motor Function Test, Modified Barthel Index for daily activities, Berg Balance Scale, and safety parameters such as coagulation markers and adverse events. This study will help determine whether this combined approach offers a more effective rehabilitation strategy for stroke survivors.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
69 (estimated)
First submitted
23 Feb 2026
Start date
1 Mar 2026
Primary completion date
1 Sept 2026
Lead sponsor
The First Affiliated Hospital of Zhengzhou University
Diseases
Stroke
NCT number
NCT07454954

What you commit to

  • Study type: Interventional
  • Planned participants: 69
  • From 1 Mar 2026 to the primary completion date, 1 Sept 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of cardiac pacemaker or other metal implants
  • Deafness, severe cognitive impairment, history of psychiatric disorders
  • Severe cardiac, hepatic, pulmonary, or renal insufficiency
  • Coagulation disorders
  • Post-stroke epilepsy
  • Malignancy

Other

  • Shoulder subluxation
  • Extensive skin damage on affected limbs
  • Pregnancy or lactation

Who the study is looking for

  • Diagnosis of stroke (ischemic or hemorrhagic) confirmed by CT or MRI, meeting the diagnostic criteria of the 4th National Cerebrovascular Disease Conference
  • First-ever stroke or recurrent stroke without residual dysfunction from prior events
  • Age 25-70 years, male or female
  • Stable vital signs, conscious, able to understand and follow therapist instructions
  • Brunnstrom stage III or above in both upper and lower limbs
  • Voluntary signed informed consent by patient or legal guardian

Age in the registry: 25 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.